Invention Grant
- Patent Title: Methods to eliminate cancer stem cells by targeting CD47
-
Application No.: US15517345Application Date: 2015-10-09
-
Publication No.: US11053314B2Publication Date: 2021-07-06
- Inventor: David D. Roberts , Sukhbir Kaur , Chengyu Liu
- Applicant: The U.S.A, as represented by the Secretary, Department of Health and Human Services
- Applicant Address: US MD Bethesda
- Assignee: The U.S.A, as represented by the Secretary, Department of Health and Human Services
- Current Assignee: The U.S.A, as represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: US MD Bethesda
- Agency: Klarquist Sparkman, LLP
- International Application: PCT/US2015/055029 WO 20151009
- International Announcement: WO2016/057980 WO 20160414
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/30 ; A61K38/18 ; A61K39/00 ; A61K39/395

Abstract:
Described herein is the discovery that cancer stem cells (CSCs) can be induced to differentiate by altering CD47 signaling. Provided herein are methods and compositions for inducing differentiation of cancer stem cells, for instance irreversible differentiation, including methods of treating subjects with cancer such as breast cancer, colon cancer, lung cancer, ovarian cancer, or melanoma, and including metastatic as well as primary cancer. Also provided are methods for treating subjects with triple negative breast cancers involving forcing differentiation of bCSCs of the subjects through targeting of CD47.
Public/Granted literature
- US20180355032A1 METHODS TO ELIMINATE CANCER STEM CELLS BY TARGETING CD47 Public/Granted day:2018-12-13
Information query